Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO

PRESSURE BIOSCIENCES, INC. (PBIO)
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

PRESSURE BIOSCIENC : Pressure BioSciences, Inc. to Discuss Third Quarter 2008 Financial Results and Provide Business Update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/14/2008 | 10:15pm CEST

SOUTH EASTON, Mass., Nov. 14 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will host a teleconference to discuss its third quarter 2008 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:

Date: Monday, November 17, 2008

Time: 4:30 p.m. Eastern Standard Time (EST)

To attend this teleconference via web-cast, please go to the Company's website: www.pressurebiosciences.com

    To attend this teleconference via telephone:
    Dial-in: (800) 344-6491
    Participant code: 3034253

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends, and will be accessible through the Company's website.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences' field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.

    Investor Contacts:
    Richard T. Schumacher, President & CEO
    Edward H. Myles, Senior Vice President of Finance & CFO
    Pressure BioSciences, Inc.
    (T) 508-230-1828

SOURCE Pressure BioSciences, Inc.


© PRNewswire 2008
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PRESSURE BIOSCIENCES, INC.
04/11PRESSURE BIOSCIENCES : Richard T. Schumacher, CEO of Pressure BioSciences, Inc.,..
AQ
04/10Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Discusses Strong Fi..
GL
04/03PRESSURE BIOSCIENCES INC : Pressure BioSciences, Inc. Reports Fourth Quarter and..
AC
04/02PRESSURE BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
03/29PRESSURE BIOSCIENCES INC : Pressure BioSciences, Inc. to Discuss Fourth Quarter ..
AC
03/14PRESSURE BIOSCIENCES : Richard T. Schumacher, CEO of Pressure BioSciences, Inc.,..
AQ
03/13Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Returns to Uptick N..
GL
02/14PRESSURE BIOSCIENCES INC : Pressure BioSciences, Inc. and ISS, Inc. Announce Two..
AC
02/09PRESSURE BIOSCIENCES INC : WallStreet Research(TM) Announces Availability of Upd..
AC
01/30PRESSURE BIOSCIENCES : CEO, Ric Schumacher, Rejoins Stock Day, Very Optimistic A..
AQ
More news